Clinical Trial Update: Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002) [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of MK-5160 in adults with Type 1 and Type 2 diabetes completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-5160

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2019-04-01